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Abstract 
Effects of Essential Oils and Amino Acid Profile on the Growth and  
Health of Receiving Cattle 
 
The objective of this trial was to evaluate the effects of amino acid profile and 
essential oil products on receiving calf growth and feed efficiency, as well as 
evaluate the effects of amino acid profile and essential oil products on fecal and 
blood Immunoglobulin A (IgA) concentrations as a marker for systemic and 
gastrointestinal tract immune status of receiving calves. One hundred-thirty 
crossbred calves (500-600 lbs) were transported to the ADM Animal Nutrition 
Research Facility in Mendon, IL. On d -1, cattle were weighed, dewormed, 
implanted, vaccinated, and a rectal temperature was recorded. An at-risk group of 
cattle was targeted for this trial. Based on initial BW and health status, cattle were 
allotted to 12 pens with 10 calves per pen so that each pen had similar weight and 
distribution of sick animals. Treatments were randomly assigned to pens with 2 
pens per treatment. Initial body weights were similar (P = 0.99) among 
treatments. Cattle were weighed on days -1, 0, 21, 42, 63, and 64. Treatments 
were arranged in a 2 x 3 factorial design of AminoGain formula (AminoGain 6 or 
AminoGain 6 Plus) and essential oil product (no essential oil, Stay Strong EO, or 
Spearmint Extract). Individual animal intake was recorded from d 0-63 using the 
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GrowSafe® cattle feeding system. Stay Strong EO was targeted to deliver 1 g / 
100 lb body weight. Based on calculations, 1.07 g/100 lb body weight was 
delivered. Preliminary analysis indicated the Spearmint Extract was composed of 
13% limonene and 70% carvone. The Spearmint Extract treatment targeted to 
deliver 40 ppm limonene and 220 ppm carvone. Once the analysis came back, the 
extract actually contained 0.08% limonene and 91.73% carvone. There is a 
possibility that limonene was oxidized to carvone subsequent to initial analysis. 
Three animals from each pen were randomly selected for fecal and sample 
collection. Blood and fecal samples were collected on d 0, 21, and 42 for analyses 
of IgA concentrations. An interaction of AminoGain 6 formulation by essential oil 
source resulted (P < 0.02) for cumulative ADG. Cumulative ADG did not differ 
(P > 0.05) with the addition of Spearmint Extract or Stay Strong EO to the 
AminoGain 6 formula. However, the addition of Spearmint Extract worsened (P 
< 0.03) cumulative ADG when added to the AminoGain 6 Plus formula. This was 
likely the result of cumulative feed intake tending (P ≤ 0.06) to be lower when the 
AminoGain 6 Plus x Spearmint Extract was fed.  IgA concentrations in blood 
were not different (P > 0.05) as a result of treatment for any of the measured time 
points. The responsiveness of IgA assay to changing disease status make it an 
effective tool to assess gross disease state of receiving cattle. Further research is 
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needed to determine the effects of using essential oil as a feed additive upon 
health and growth of cattle.  
 
Keywords: Amino Acids, Essential oils, IgA, GrowSafe System, Beef Cattle  
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Definition of Terms/Abbreviations 
Amino Acids (AA)- the building blocks from which all bodily proteins are made 
in the body. There are 20 known standard amino acids forming various proteins. 
Ten are called essential amino acids and the other ten are non-essential amino 
acids 
Acid Detergent Fiber (ADF)- the residue remaining after boiling a forage 
sample in acid detergent solution. ADF contains cellulose, lignin, and silica.  
Arginine (ARG)- essential amino acid that protects intestinal mucosal against E. 
coli/LPS-induced damage to intestinal barrier function; increases intestinal IgA 
concentrations; lowers inflammatory cytokines in intestine; involved in immune 
cell function  
Ash- a measure of the total mineral content; the residue remaining after burning a 
sample.  
Average Daily Gain (ADG)- pounds gained per day 
Average Dry Matter Intake (ADMI)- Dry Matter Intake ÷ Number of Days  
Bovine Respiratory Disease (BRD)- affects the upper and lower respiratory 
tracts and can lead to pneumonia. This disease is considered the most 
economically significant disease of fed cattle in the United States. 
Carvone- component of caraway dill and spearmint seeds; has both antibacterial 
and antifungal activity 
Carvacrol- primary essential oil in scotch spearmint, found in oregano, thyme, 
pepperwort, and bergamot 
Crude Protein (CP)- the crude protein content of a feed sample represents the 
total nitrogen (N) in the diet. This value is 6.25 times the nitrogen content for 
forage or 5.7 times the nitrogen content for grain.  
Corn Steep Liquor (CSL)- a by-product of wet corn milling and is a viscous 
liquid mixture of soluble protein, amino acids, carbohydrates, organic acids, 
vitamins, and minerals. 
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Cysteine (CYS)- non-essential amino acid that decreases oxidative stress in 
intestine; increased crypt cell proliferation 
Hundredweight (cwt)- unit of weight equal to 100 pounds  
Dry Matter (DM)- That part of feed, which is not water. Percent DM = 100% - 
moisture %. Feed values and nutrient requirements for ruminants are expressed on 
a dry matter or moisture-free basis to compensate for the large variation in 
moisture content of feeds commonly fed to cattle. 
Dry Matter Intake (DMI)- As Fed Intake × % Dry Matter  
Electronic Identification Tag (EID)- ear tag used for identification with 
GrowSafe System® to calculate feed intakes  
Essential Oils (EO)- the naturally occurring secondary metabolites that can be 
extracted from plant tissues.  
Ether Extract- portion of dry matter extracted with ether. Used to measure crude 
fat.  
Farm Identification Tags (FID)- ear tag used for identification at farm 
Gain to Feed ratio (G:F)- a measure of an animal's efficiency in converting feed 
nutrients into increased body mass 
Grams (g)- metric unit of mass  
Grams per Day (g/d)- metric unit of mass used per day  
Gram Negative Bacteria- bacteria normally found in the gastrointestinal tract 
that is responsible for diseases; have a thin cell wall; E. coli is an example of this 
bacteria. This bacteria does not stain with gram stain because of its protective 
layer.  
Gram Positive Bacteria- good bacteria, live in the gut and help digest food; have 
a thick cell wall. This bacteria stains with gram stain because it doesn’t have a 
protective membrane. 
Histidine (HIS)- essential amino acid that is the precursor for histamine. 
Histamine is involved in the local immune response to invading proteins. 
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Increases permeability of capillaries to white blood cells and proteins that target 
against invading proteins.  
Immunoglobulin A (IgA)- a major class of immunoglobulins (antibodies) found 
in serum and external body secretions, as well as in the gastrointestinal and 
respiratory mucosa. 
Ionophore- any molecule, as of a drug, that increases the permeability of cell 
membranes to a specific ion and facilitates the transport of ions across a cell 
membrane 
Limonene- primary essential oil in scotch spearmint, found in citrus oil and can 
be oxidized to carvone  
Megacalorie (Mcal)- 1,000,000 calories  
Methionine (MET)- essential amino acid that decreases oxidative stress in 
intestine; increased crypt cell proliferation 
Milliliter (ml)- unit of capacity  
Modified Distillers Grains plus solubles (MDGS)- a co-product from ethanol 
production, a modified wet product partially dried down, and a common additive 
to cattle feed for added protein and fat  
Nanograms (ng)- unit of mass; one billionth of a gram  
Net Energy for Gain (NEg)- an estimate of the energy in a feed used for body 
weight gain once maintenance is achieved 
Net Energy for Maintenance (NEm)- an estimate of the energy in a feed used to 
keep an animal in energy equilibrium, neither gaining weight nor losing weight. 
Neutral Detergent Fiber (NDF)- the residue left after boiling a sample in neutral 
detergent solution. The NDF in forages represents the indigestible and slowly 
digestible components in plant cell walls.  
Parts per Million (ppm)- unit of concentration for small values 
Ryelage- forage that is chopped at a higher moisture content, then sealed in a 
plastic wrap. 
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Threonine (THR)- essential amino acid that is involved in mucin synthesis and 
intestinal structure. 
Total Digestible Nutrients (TDN)- a measure of the energy value in a feedstuff. 
Total Mixed Ration (TMR)- a homogeneous mixture of mechanically mixed 
ration ingredients that typically combine forages and concentrates such as grains 
to optimize animal performance
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Chapter I 
Introduction 
Cattle arriving at the feedlot have experienced stress as a result of 
transportation, inadequate feed and water, and co-mingling with other animals. 
These factors result in increased risk of disease outbreak and death.  
Cattle farmers strive to maintain a healthy crop of cattle and in turn spend 
a substantial amount of money each year to keep their herd safe from diseases. 
This can include the money spent on their health care, such as vaccinations, 
deworming, fly control, antibiotics, and implants, as well as the various feed 
additives like vitamins, minerals, and growth promoters. In recent years, there has 
been an increased public concern over antibiotic use in food animals due to the 
concern regarding antibiotic resistance and adverse effects upon human health due 
to antibiotic residues in meat. Consequently, microbiologists and nutritionists 
have begun researching alternative products, which can be used instead of 
antibiotics and growth promoters, promoting optimal patterns of rumen 
fermentation, improving feed efficiency and animal productivity. Among these 
alternatives is a renewed interest in essential oils, as well as amino acids 
(Benchaar et al., 2008).     
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The amino acids (AA) that were focused on in this trial were methionine, 
arginine, histidine, threonine, and cysteine. These AA have been implicated in 
unique paths that enable the animals to initiate and then manage an immune 
response (Ruth & Field, 2013). The differences in AA profile between AminoGain 
6 and AminoGain 6 Plus were achieved by adding fishmeal, blood meal, and 
bypass soybean meal.  
The essential oils studied in the trial were Stay Strong Essential Oils (SS 
EO; Ralco Inc., Marshall, MN) and Scotch Spearmint Extract. The SS EO was fed 
at the manufacture’s recommendation of 1 g/100 lb BW. It is an oregano based 
product which contains essential oils. Carvacrol, the oil of oregano which is 
derived from oregano seeds, can also be generated from carvone, the oil of 
spearmint, through acid-catalyzed isomerization (Kjonaas & Mattingly, 2005 and 
Baser, 2008). Carvacrol can also be found in thyme, pepperwort, and wild 
bergamot. Carvacrol offers a wide range of health benefits, including 
antimicrobial, antitumor, analgesic, anti-inflammatory, anti-parasitic, and aid in 
gastrointestinal diseases (Baser, 2008).  
The Scotch Spearmint Extract that was used is a recycled mint oil which 
was accumulated through the second distillation; a process farmers do to clean 
their pipes; at peppermint and spearmint farms in Indiana. Due to this being a 
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recycled mint oil, it comes with a low cost, as opposed to the mint oil that is sold 
to gum and toothpaste companies. The farm that the scotch spearmint oil was 
acquired from, also produces spearmint and peppermint. The scotch spearmint oil 
used in this trial was selected because after initial lab analysis, it contained the 
highest amount of limonene (13%) and contained 70% carvone.  
Limonene is a hydrocarbon cyclic terpene that is abundant in lemons, 
oranges, and grapefruit and is active against gram-negative bacteria (Castillejos et 
al., 2006). For the trial, it was determined to target 40 ppm limonene, which in 
turn provided 220 ppm carvone. The amount of 40 ppm limonene was targeted 
because of the trial done by Elwakeel et al. (2013), where the effect of limonene 
on F. necrophorum (bacteria found in foot rot and liver abscesses) growth in vitro 
was studied. These results suggested that 20-100 ppm limonene can be a 
promising tool to naturally reduce F. necrophorum and subsequently control liver 
abscesses. Therefore, it was chosen to start at 40 ppm, as that was somewhat 
intermediate.  
Immunoglobulins (Ig), also known as antibodies, are proteins produced by 
plasma cells and lymphocytes (Miller-Keane Encyclopedia and Dictionary of 
Medicine, Nursing, and Allied Health, 2003). There are five classes of 
immunoglobulins found in mammals: IgA, IgD, IgE, IgG, and IgM. In cattle, the 
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Ig classes that have been recognized are IgM, IgA, IgG1, IgG2 and IgE 
(Naessens, 1997). Immunoglobulin A (IgA) was chosen as the metric to measure 
in this trial because it is found in both serum and intestinal mucosa. While IgA is 
naturally present in the serum, elevated IgA concentrations are associated with 
inflammatory responses. Immunoglobulin A is the most abundant Ig in the 
respiratory and intestinal mucosa and it serves as a first line of defense against 
bacterial and viral invasion from the environment. Immunoglobulin A can also be 
found in secretory fluids such as saliva, tears, and nasal secretions (Saunders 
Comprehensive Veterinary Dictionary, 2007). To evaluate these IgA levels a 
Bovine IgA ELISA Kit (Bethyl Laboratories, Inc., Montgomery, TX) was used 
and read through an Epoch Plate Reader (BioTek, Winooski, VT). 
All collection of feed data was done through the GrowSafe System® 
(Model 6000; GrowSafe Systems Ltd., Airdrie, Alberta, CA). The GrowSafe 
System® is a great benefit to have in a feed trial because it calculates what each 
animal consumes per meal and then determines a total amount they consumed 
daily. This technology allows for each individual animal to be used as an 
experimental unit, rather than the whole pen be one experimental unit. The system 
is extremely accurate and tracks feed consumed down to the hundredth of a 
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pound. It can also be helpful in identifying when an animal is sick because their 
feed intake typically decreases.    
The aim of the study was to evaluate effectiveness of feeding essential oils 
and targeted amino acids to alleviate decreased growth in receiving cattle. It was 
also sought after to determine if there was a specific link between either essential 
oils or amino acids and improved growth performance or immune status of 
receiving cattle. It is hypothesized that receiving cattle offered scotch spearmint 
extract and a rumen undegradable protein-amino acid profile focused on immune 
response will have improved growth and feed efficiency.  
 
Statement of the problem 
In-light of increased regulation of prophylactic use of antibiotics for the 
prevention of disease outbreak in receiving cattle, there is a need for a more 
accepted form of prevention.  
 
Purpose of the Study 
The purpose of this study is to evaluate the efficacy of feeding essential oils and 
targeted amino acids to mitigate decreased growth in receiving cattle.  
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Research Questions 
(1) Do amino acids and essential oil products affect receiving calf growth and 
feed efficiency? 
(2) Do amino acids and essential oil products affect fecal and blood IgA 
concentrations of receiving calves?  
 
Conceptual Framework 
Since there is a great deal of public concern over the use of antibiotics in 
livestock production, it is important to look for alternatives for treating disease, as 
well as improving feed efficiency. Essential oils provide antibacterial, antifungal, 
and antioxidant properties that make them useful as a natural additive in feed. 
Whereas, amino acids have been identified in maintaining intestinal growth, 
function, normalizing the inflammatory response, and secretion of IgA by 
mucosal cells.  
 
Assumptions 
(1)  It is assumed that the targeted amino acids and essential oils will benefit 
calf growth and feed efficiency.  
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(2)  It is assumed that the targeted amino acids and essential oils will assist the 
immune response of the sick cattle.  
 
Delimitations 
This study will not investigate the treatments on different breeds or ages of 
cattle. 
 
Limitations 
This study is limited to a 63-day trial at the ADM Research Center in 
Mendon, IL. This study is limited to Angus/Simmental cross cattle. This study is 
limited to six different feed treatments and two replicate pens per treatment.  
 
Significance of the Study 
This study is significant because of the public concern over use of 
antibiotics. In the past decade, the addition of antibiotics in livestock production 
has been common, but now there is apprehension of antibiotic resistance and 
possible risks to human health due to residues in the final product or excretion to 
environment.  
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Organization of the Study 
The study began with research of relevant literature, followed by a 63-day 
trial that ran from October 11th- December 13th, 2016.  
 
Chapter Summary 
This study examined the effect of essential oils and amino acid profile 
products on receiving calf growth and feed efficiency. It also evaluated the effects 
of essential oils and amino acid profiles on IgA concentrations as a marker for 
systemic and gastrointestinal tract immune status of 120 crossbred calves.  
Over the last decade, antibiotic use in livestock production has been 
common. Although, recently there has been grave public concern of their use due 
to the potential of antibiotic resistance and the transmission to human from 
livestock causing various health risks. Potential alternatives to antibiotics are 
essential oils and amino acids. Essential oils provide antibacterial, antifungal, and 
antioxidant properties that make them useful as a natural additive in feed 
(Castillejos et al., 2006). Whereas, amino acids have been identified in 
maintaining intestinal growth, function, normalizing the inflammatory response, 
and secretion of IgA by mucosal cells (Ruth & Field, 2013).  
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Chapter II 
Review of Relevant Literature  
Introduction 
Antibiotics are used for a variety of reasons in ruminant livestock. They 
are used for the treatment or prevention of disease, the manipulation of rumen 
microbe population, and to lower gut integrity. Some antibiotics used in livestock 
are relevant to human medicine and others are not. Antibiotics that are used in 
both livestock and human medicine could be a reason of stricter guidelines on 
treatment of animals.  
In 1928, Alexander Fleming discovered Penicillin, along with the 
development of techniques to produce antibiotics on an industrial scale. In the 
1950s, microbiologists began to identify bacteria that were resistant to antibiotics. 
By the 1980s, various drug-resistant bacteria were common. Some antibiotics 
used in livestock production are also relevant for human medicine. Presently, 
there is dispute concerning the causes of antibiotic resistance and what should be 
done about it. (Russell & Houlihan, 2003). This, as well as the increased 
regulation of antibiotics for the prevention of disease in cattle, are the reasons to 
evaluate a more accepted form of treatment.  
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Research documents have shown that a deficiency of protein or amino 
acids can weaken the immune function and increase the susceptibility of animals 
to disease (Peng et al., 2007) Although, more recently, studies have reported that 
more important than protein, is the composition of certain amino acids for the 
animals experiencing an immune challenge (Ruth & Field, 2013). The dietary 
supplementation of essential amino acids to animals experiencing malnutrition or 
infectious disease enhances the immune status, therefore reducing morbidity and 
mortality rates in cattle (Peng et al., 2007).  
Two-thirds of the decrease in growth in livestock facing an immune 
challenge is associated with a decrease in feed intake associated with diseased 
animals. The other one-third of decreased growth has been credited to nutrients 
being separated away from growth and toward initiation of the immune response 
for fever mitigation, altered metabolism, recovering of damaged tissue, and the 
inability to absorb nutrients from the gastrointestinal tract (Klasing, 2016).    
One of the main reasons that farmers and ranchers strive to have healthy 
cattle, is to help prevent Bovine Respiratory Disease (BRD) and also known as 
‘shipping fever’. Bovine Respiratory Disease affects the upper and lower 
respiratory tracts and can be associated with lung infection, which may ultimately 
lead to pneumonia. This disease is considered the most economically significant 
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disease of fed cattle in the United States. The North America Bovine Respiratory 
Disease Treatment Market was estimated at $24.5 million in 2016 and is expected 
to reach $67.31 million by 2021. The U.S. feedlot industry approximates the loss 
related to BRD is due in part to loss of production, increase in labor expenses, 
pharmaceutical costs, and death from BRD (BRD Treatment Market, 2016). The 
disease is said to be responsible for 65-80% of morbidity and 45-75% mortality in 
feedlot cattle (Jelinski & Janzen, 2016). There are various factors that can cause 
BRD, including marketing, weaning shipping, co-mingling, a weather change, 
nutrition, and various respiratory viruses (Currin & Whittier, 2009). Signs of BRD 
include lack of appetite, nasal discharge, difficulty breathing, depression and 
fever of 104°F to 108°F (Jelinski & Janzen, 2016). Calves often start showing 
signs of illness between 7-21 days after being purchased, but can occur anywhere 
from 2-30 days after being purchased (Currin & Whittier, 2009).  
One of the most popular ways to treat BRD, is with antibiotics, such as 
these injectibles: Micotil®, Nuflor®, and Baytril 100® (Currin & Whittier, 2009). 
Although, in the recent years, there has been an increase in public concern 
regarding the use of antibiotics in livestock production. This is mostly due in part 
to their possible contribution to the development of antibiotic resistant bacteria 
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and the transmission of antibiotics from livestock to humans (Benchaar et al., 
2008).  
Typically, beef cattle in feedlots are fed a class of antibiotics known as 
ionophores. Although there are some exceptions, gram-positive bacteria in the 
rumen are classically more sensitive to ionophores than gram-negative bacteria 
are. Through their antimicrobial activities, ionophores are capable of increasing 
feed efficiency by as much as 10%. A well-known and widely used ionophore is 
monensin, which was approved by the FDA in the 1970s. Monensin increases 
feed efficiency in ruminants by altering their ruminal fermentation, but is not in 
the class of medically-important antibiotics (Russell & Houlihan, 2003).  
One of the possibilities of natural alternatives to antibiotics is essential 
oils. There are several uses of essential oils as feed additives for livestock because 
they can improve feed efficiency and animal productivity due to their 
antimicrobial, anti-inflammatory, anti-oxidant, and digestive effects on rumen 
metabolism (Rivaroli et al., 2016). Essential oils are naturally occurring 
secondary metabolites that are extracted from plant tissues through a steam 
distillation process (Benchaar et al., 2006). Essential oils are a potential substitute 
to antibiotics because they have been reported to possess strong antimicrobial 
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effects against a wide range of microorganisms including bacteria, fungi, viruses, 
and protozoa (Benchaar et al., 2006).   
Essential oils are responsible for the odor and color of both plants and 
spices. They possess antibacterial, antifungal, antimicrobial and antioxidant 
properties which make them beneficial in animal feeds as natural additives. 
Essential oils can be composed of more than one-hundred individual components. 
(Castillejos et al., 2006). In scotch spearmint, the primary components are 
carvacrol and limonene. Limonene also can be found in lemons, oranges, 
grapefruit, peppermint, spearmint and other oils (Castillejos et al., 2006). 
Carvacrol can be found in oregano, thyme, pepperwort, and wild bergamot and is 
responsible for the antibacterial properties of many essential oils. The main active 
ingredient in oregano is Carvacrol, which is derived from oregano seeds. It offers 
a wide range of health benefits, including antimicrobial, antitumor, analgesic, 
anti-inflammatory, anti-parasitic, and in gastrointestinal diseases (Baser, 2008). 
Carvacrol, the oil of oregano, can also be generated from carvone, the oil of 
spearmint, through acid-catalyzed isomerization (Kjonaas & Mattingly, 2005).  
One of the most important undertakings of compounds in essential oils are 
their ability to have a wide spectrum of antimicrobial activity. Both gram positive 
and gram negative bacteria exist in the rumen. Generally, gram-positive bacteria 
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are more sensitive to essential oils than gram-negative bacteria (Castillejos et al., 
2006). This is because most components of essential oils are lipophilic, meaning 
they cannot penetrate in the membrane of gram-negative bacteria. Carvacrol, 
since it is an aromatic hydrocarbon and has a low molecular weight, is able to 
interact with water, cross the cell wall of gram-negative bacteria by diffusion, and 
interact with the lipid bilayer of cells. While the addition of essential oils may 
increase weight gain similar to that of synthetic antibiotics, there is little scientific 
evidence of their effect on rumen microbial fermentation (Calsamiglia et al., 
2007). One of the purposes of this research was to determine if certain essential 
oils would have a positive impact on growth, feed efficiency, or perhaps an 
indirect indication of impact rumen fermentations, as well as fecal and blood IgA 
as markers of gastrointestinal or systemic immunity.   
Essential oils are made up of more than one-hundred individual 
components. Major components can constitute up to 95% of the essential oil, 
while others may be present only in traces (Castillejos et al., 2006). Spearmint oil 
has a minimum of 51% carvone, but typically has a content of 60-70% carvone 
and 8-15% of limonene. Carvone is produced through both extraction and 
purification of essential oils from caraway, dill, and spearmint seed. Carvone has 
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the properties to be both antibacterial and antifungal (De Carvalho & Fonseca, 
2006).  
Another aspect that this trial observed was whether or not an increase in 
amino acids (AA) had effects receiving calf growth and feed efficiency. In 
addition to essential oils, the trial also evaluated the effects of AA profile within a 
targeted group of sick cattle. AA are the building blocks of protein and are used 
for the development of tissues and muscle production. It takes at least 50 amino 
acids to make up a protein and there are twenty different amino acids. There are 
ten essential amino acids, including phenylalanine, valine, threonine, tryptophane, 
isoleucine, methionine, histidine, arginine, leucine, and lysine. The term 
"essential" amino acid refers to the amino acids that cattle cannot produce 
themselves. Each essential amino acid must be supplied through the diet or from 
rumen microbes. Cattle also require “nonessential” amino acids, but they are able 
to synthesize them in the adequate amounts that are needed. The rumen microbes, 
degraded dietary protein and amino acids, and endogenous amino acids all 
contribute to the amount of amino acids exiting the rumen and available to be 
absorbed in the small intestine of the animal. Rumen microbial amino acids 
contribute the majority of the total amino acids, about 50-75%. (Ondarza, 2004).  
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There is a possibility that an increase in targeted amino acids in the rumen 
undegradable protein could be greatly beneficial to sick cattle. During an immune 
challenge, the liver shifts from being a metabolic organ directing nutrients, 
predominantly amino acids, toward growth to be an immune organ directing 
nutrients to combat the immune challenge (Klasing, 2016). Amino acids arginine 
(ARG), cysteine (CYS), methionine (MET), histidine (HIS), and threonine (THR) 
have been implicated to enable the animal to initiate and then manage the immune 
response (Ruth & Field, 2016; Jutel et al., 2006). The dietary amino acid profile 
that is desired during an immune challenge differs from a healthy growing animal 
as animal metabolism has shifted (Klasing, 2016). The amino acids previously 
identified have been implicated in maintaining intestinal growth and function, 
normalizing the inflammatory response, and secretion of IgA by mucosal cells 
(Ruth & Field, 2013).   
The AA that were focused on in this trial were methionine, arginine, 
histidine, threonine, and cysteine. These AA have been implicated in unique paths 
that enable the animals to initiate and then manage an immune response. They 
each have unique properties such as, maintaining the integrity, growth and 
function of the intestine, and the secretion of IgA. Methionine and cysteine help 
reduce intestinal oxidative stress and increase crypt cell proliferation. Arginine 
protects intestinal mucosa against E. Coli, increases intestinal IgA concentrations, 
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lowers inflammatory cytokines in the intestine, and is involved in immune cell 
function. Threonine is involved in mucin synthesis, as well as intestinal structure. 
Histidine is a precursor for histamine, which is involved in local immune response 
to invading proteins. Histidine is also a vasodilator, which means it helps increase 
permeability of capillaries to white blood cells and proteins that target invading 
proteins (Ruth & Field, 2013). A deficiency in AA has been reported to impair 
immune function and increase susceptibility of animals to infectious disease. 
Therefore, dietary supplementation of specific AA to animals with malnutrition 
and infectious disease challenges may enhance the immune status, thus reducing 
morbidity and mortality rates (Peng et al., 2007). An increase in AA was 
accomplished by adding fishmeal, blood meal, and bypass soybean meal which 
are all desirable sources of AA and bypass rumen degradation.   
Methionine is often the first limiting amino acid for growing cattle and is 
also a part of a wide variety of metabolic pathways. It can even serve as a 
precursor to other amino acids, like cysteine. Both methionine and cysteine can 
help protect proteins and cells from oxidation. It has been found that growing beef 
cattle can benefit from 5-10 g/d of additional methionine because it aids in 
improving performance in beef cows, including increased average daily gain, 
improved reproductive tract scores and reproductive efficiency. Since methionine 
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plays several roles in an animal’s metabolism and it cannot produce this essential 
amino acid on its own, it is important to supplement the diet (Nuzback, 2013).  
Immunoglobulins are major components of the humoral immune response 
system, meaning it is the body’s defense in the immune system that protect 
against infection.  Immunoglobulins are made up of lymphocytes and plasma cells 
and are found in the serum, as well as other body fluids and tissues, including 
urine, spinal fluid, lymph nodes, and in the digestive tract. Each immunoglobulin 
molecule consists of four polypeptide chains; two heavy chains (H chains) and 
two light chains (L chains). There are five different kinds of H chains that 
differentiate immunoglobulins. The five major immunoglobulins are IgA, IgD, 
IgE, IgG, and IgM. Two types of IgA have been identified. They are serum IgA 
and secretory IgA (sIgA). Secretory IgA is present in saliva, bile, synovial fluid, 
as well as intestinal and respiratory tract secretions. Both IgA types are known to 
have antiviral properties (Saunders Comprehensive Veterinary Dictionary, 2007). 
IgA was chosen as the metric to measure in this trial because it is found in both 
serum and intestinal mucosa. While IgA is present in the serum, it is mostly only 
detected during an inflammatory response, this was beneficial since immune 
challenged cattle were targeted for this trial (Saunders Comprehensive Veterinary 
Dictionary, 2007). 
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Summary 
 
The reasoning of further research into natural alternatives of antibiotics is 
due to the dispute of concern of antibiotic resistance and the increased regulation 
of antibiotics in livestock production. Bovine Respiratory Disease is just one 
example of the diseases that affect cattle population and the impact that disease 
alone makes on the cattle industry proves the importance of finding alternatives to 
antibiotics. Potential options to help combat these issues are essential oils and 
amino acids.   
There are several capabilities of essential oils as feed additives. They can 
improve feed efficiency, as well as animal productivity due to their antimicrobial, 
anti-inflammatory, anti-oxidant, and digestive effects on rumen metabolism 
(Rivaroli et al., 2016). While AA have been implicated in unique paths that enable 
the animals to initiate and then manage an immune response. The AA focused on 
in this trial each have unique properties of maintaining the integrity, growth and 
function of the intestine, and the secretion of IgA (Ruth and Field, 2013).  
Immunoglobulins are a defense system in the immune system that helps 
protect against infection (Saunders Comprehensive Veterinary Dictionary, 2007). 
IgA was chosen as the metric to measure in this trial because it is found in both 
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serum and intestinal mucosa. While IgA is present in the serum, it is mostly only 
detected during an inflammatory response, this was beneficial since immune 
challenged cattle were targeted for this trial (Saunders Comprehensive Veterinary 
Dictionary, 2007). 
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Chapter III: Methodology 
Introduction 
Each year, farmers strive to maintain a healthy crop of cattle and in turn 
spend a substantial amount of money to keep their herd safe from diseases. This 
can include, but not limited to, the money spent on vaccinations, antibiotics, 
deworming, vitamins and minerals, and various other feed additives. On the 
contrary though, in recent years there has been an increase in public concern over 
the use of antibiotics. As well as regulation of prophylactic use of antibiotics for 
the prevention of disease outbreak in receiving cattle. So, in turn, a more accepted 
form of treatment is preferred, which will also hopefully be cost efficient.   
This study took place at the ADM Research Center in Mendon, Illinois. 
The objectives of this trial were to evaluate: 1) effects of amino acid profile and 
essential oil products on receiving calf growth and feed efficiency and 2) effects 
of amino acid profile and essential oil products on fecal and blood 
Immunoglobulin A (IgA) concentrations as a marker for systemic and 
gastrointestinal tract immune status of receiving calves. All animal care and 
protocols used in this experiment were approved by the ADM Research Center’s 
Animal Care and Use Committee.  
 
33 
 
Rationale 
Quantitative Research was used in this study. The examples of 
quantitative research used include: weight, Average Daily Gain (ADG), Average 
Feed Intake (AFI), Dry Matter Intake (DMI), Average Dry Matter Intake (ADMI), 
Gain to Feed Ratio (G:F), as well as ELISA testing for IgA concentration. 
Experimental research was used since an experiment was conducted in order to 
give evidence to the experimental hypothesis. 
 
Research Questions 
(1) Do amino acids and essential oil products affect receiving calf growth and 
feed efficiency? 
(2) Do amino acids and essential oil products affect fecal and blood IgA 
concentrations of receiving calves?  
 
Context of the Study 
This study took place at the ADM Research Center in Mendon, IL. 
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Data Collection Methods  
In this study, 130 crossbred calves (570.1 ± 4.49 lbs) were brought in for a 
63-d trial. Upon arrival to the facility, cattle were weighed, dewormed with an 
Vetrimec™ pour-on (Norbrook Laboratories Ltd., Overland Park, KS), implanted 
with Synovex-S® (Zoetis, Kalamazoo, MI), vaccinated with Express® 5 
(Boehringer Ingelheim, St. Joseph, MO) and a rectal temperature was recorded.  
Upon arrival and initial observation, the animals were classified as healthy 
or sick. To be classified as sick, calves had to exhibit at least one of the following: 
rectal temperature greater than 102.5°F, nasal discharge, respiratory distress, or 
lethargy. The animals were weighed on day -1 and day 0 (for an average start 
weight), d 21, d 42, and then on days 63 and 64 (for an average end weight). 
Consecutive-day weights at the beginning and end of the trial were averaged to 
minimize variation resulting from rumen fill. Calves were then allotted to one of 
twelve pens based on BW and health status, with ten animals in each pen. In each 
pen, approximately 70-75% of the animals were classified as sick, leaving 25-
30% healthy animals. Treatments were then randomly assigned to pen.  
Three animals from each pen were randomly selected for fecal and blood 
sample collection. Using the same designated animals each time, blood and fecal 
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samples were collected on d 0, 21, and 42. Blood samples were allowed to 
coagulate for 1 hour at room temperature and then centrifuged for collection of 
serum. Serum and feces were stored at -4 oF for subsequent analyses of IgA. The 
samples were evaluated for IgA using an Epoch Plate Reader (BioTek, Winooski, 
VT) and a Bovine IgA ELISA kit (E11-131, Bethyl Laboratories, Inc., 
Montgomery, TX).  
Table 1 below illustrates a timeline of events for this trial.  
 
 
 
Table 1. Experimental Timeline 
Day Event 
Arrival to test start Grass hay and water ad libitum 
October 10th d  -1 - Weigh am pre-feeding 
October 11th d   0 - Weigh am pre-feeding 
- Collect fecal and blood samples on subset 
- Allot to pens 
- Start test diets 
  
November 1st d 21 - Weigh am pre-feeding 
- Collect fecal and blood samples on subset 
November 22nd d 42 - Weigh am pre-feeding 
- Collect fecal and blood samples on subset 
December 13th d 63 - Weigh am pre-feeding 
December 14th d 64 - Weigh am pre-feeding 
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There were six different diets for this trial. The diets were as follows: 
1. AminoGain 6- Control 
2. AminoGain 6- Stay Strong Essential Oils 
3. AminoGain 6- Scotch Spearmint Extract 
4. AminoGain 6 Plus- Control 
5. AminoGain 6 Plus- Stay Strong Essential Oils 
6. AminoGain 6 Plus- Scotch Spearmint Extract 
 
To help analyze the results of this study, quantitative statistics were used. 
When allotting animals to pens, cattle were stratified by weight and sickness to 
make each pen a replicate, with regard to initial weight and degree of sickness, as 
well as an effort to ensure the degree of sickness the same across all treatments so 
there would not be a statistical difference.  
Sub-samples of each ingredient and the total mixed rations (TMR), were 
taken each week and pooled at the end of the trial for analysis. 
The collection of feed data was done through the GrowSafe System® 
(Model 6000; GrowSafe Systems Ltd., Airdrie, Alberta, CA). Each individual 
animal had an electronic tag placed in their ear at initial processing. The 
GrowSafe System® tracks every time the animals reached their head in the bunks, 
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the amount they consumed, how many times they ate, and for what length of time. 
These recordings were taken twenty-four hours a day.  
Tables 4.2 and 4.3 depict that the treatments were designed to have a 
similar ingredient composition and deliver similar energy, crude protein, vitamins 
and mineral. Treatments were arranged in a 2 x 3 factorial design of AminoGain 
formula (AminoGain 6 or AminoGain 6 Plus) and essential oil product (no 
essential oil, Stay Strong EO (SS EO), or Scotch Spearmint Extract). Stay Strong 
EO was included in the supplement to deliver 1 g / 100 lb BW. On average each 
animal consumed 7.38 g SS EO each day, consequently delivering 1.07 g/100 lb 
BW. Preliminary analysis indicated the Spearmint Extract was composed of 13% 
limonene and 70% carvone. Calculations for the initial amounts of supplement to 
be added to the treatment diets were figured using these numbers. Therefore, 
Spearmint Extract was included in the supplement to deliver 40 ppm limonene 
and 220 ppm carvone. When the actual analysis came back, the extract contained 
0.08% limonene and 91.73% carvone. A limonene concentration of 40 ppm was 
chosen based on the trial done by Elwakeel et al. (2013), where 20-100 ppm 
limonene decreased F. necrophorum (bacteria found in foot rot) growth in vitro 
and subsequently controlled liver abscesses. However, only limonene was used in 
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the Elwakeel et al. (2013) trial, the potential exists for carvone to have similar 
effects because of the similarities in the compounds. 
 
 
Data Analysis 
At the end of the trial, all of the samples of the ingredients were pooled 
together. The pooled samples were analyzed in our lab for the following: Dry 
Matter, Crude Protein, Acid Detergent Fiber (ADF), Neutral Detergent Fiber 
(NDF), Ether Extract (EE), Ash, minerals, as well as Total Digestible Nutrients, 
NEg (Net Energy for Gain), and NEm (Net Energy for Maintenance). The TMR 
composites was retained in the freezer pending results on individual ingredients.  
The IgA in the blood and fecal samples were evaluated using the Epoch 
Plate Reader (BioTek, Winooski, VT) and a Bovine IgA ELISA kit (E11-131, 
Bethyl Laboratories, Inc., Montgomery, TX). Since this was the first time using 
this plate reader, it was determined to run the samples in triplicates to better the 
chances of a repeatable assays. Seven different standards ranging from 15.75-
1,000 ng/ml were used. The process for serum IgA analyzation is as follows: 
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A. Dilute 10 microliters of serum with 7.5 ml of Buffer C. Mix well.  
B. Add 100 microliters of each sample and standard to the wells. Do in 
triplicate. Cover the wells with adhesive sheet and let sit for one hour 
at room temperature.  
C. Remove adhesive sheet and rinse 4 times with wash buffer.  
D. Pour Detection Antibody reagent into V shaped tray. Add 100 
microliters to each well using multichannel pippeter. Mix well by 
gently tapping side several times.  
E. Add adhesive cover and incubate for one hour at room temperature. 
Follow with rinsing with wash buffer 4 times. 
F. Pour HRP Solution C into clean V shaped tray. Add 100 microliters 
using multichannel pippeter. Incubate at room temperature for 30 
minutes covered with adhesive cover.  
G. Pour TMB Substrate Solution into clean V shaped tray. Add 100 
microliters using multichannel pippeter. Place in dark drawer for 40 
minutes uncovered.  
H. Pour Stop Solution into clean V shaped tray. Add 100 microliters 
using multichannel pippeter. Tap plate to mix. The solution in the 
wells should change from yellow to blue. Place within Epoch Plate 
Reader for a reading within 30 minutes.  
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Once the results were achieved, the mean, standard deviation, and percent 
coefficient variation were calculated using Microsoft Excel®. The mean was 
calculated using the ‘=average’ function and the standard deviation was calculated 
using the ‘=stdev’ function. The percent coefficient variation was calculated by 
dividing the standard deviation by the mean and then multiplying by 100. The 
percent coefficient variation gives the variation of results obtained from repeated 
experiment and helps determine the outliers in the results. If the result was above 
10, the sample was rerun.  
For the fecal IgA analysis, two different protocols were attempted to 
develop an assay. The first involved thawing the frozen feces, bringing it to room 
temperature, and then placing it in purified water at a concentration of 10% by 
weighing up 1 gram of feces and adding 9 ml of water. The samples were then 
vortexed and incubated overnight before being spun at 2,000 x g for 15 minutes. 
Afterwards, it was diluted with 10 microliters of the supernatant with 7.5 ml of 
Buffer C and mixed. The same Bovine IgA ELISA kit used in the serum IgA 
process was used for the fecal IgA as well, therefore the steps were the same as 
listed above. As with the serum IgA analysis, the fecal samples were also ran in 
triplicates and seven standards were used running from 15.75-1,000 ng/ml. After 
achieving low results using the first protocol, 5 g of the fecal material was used to 
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increase sensitivity. With an increase in feces, higher concentrations in the results 
were achieved. However, the results varied, this may be due in part to the animals 
not being as sick as we had assumed. The assay was determined to effectively 
detect IgA in bovine fecal material, but results were lower than expected, so fecal 
testing ceased and is not reported for these animals.  
 
Reliability, Validity, Generalizability, Triangulation 
Data were analyzed using SAS software (SAS Inst. Inc., Cary, NC) with 
individual animals as the experimental unit. Treatment, pen, and animals were 
independent fixed effects in the model. Differences in dependent variable means 
that result from AminoGain formula or essential oil product or their interaction (for 
individual intake, average daily gain, and feed conversion efficiency) were 
separated by least square means using the p-diff option. Fecal and serum IgA 
concentrations were evaluated as repeated measures.  
 
Advantages and Disadvantages of Strategy and Methods  
The advantages of this strategy and methods are the two different types of 
samples (fecal and serum) that were taken from the animals, as well as the   
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randomization of animals chosen to be sampled. Another advantage was that the 
GrowSafe System® was used. Using this system allowed the possibility to have 
120 experimental units (animals) rather than 12 experimental units (pens) because 
the precise amount of what each animal consumed was known. Other advantages 
include as well as the same mixer used for all of the different diets and the same 
individual mixed the diets each time.  The disadvantages of the methods is that 
only three samples from each pen were taken pen, instead of sampling every 
animal. Another disadvantage is the length of the trial, there may have been 
different results had the trial been over a longer period of time.  
 
 
Chapter Summary 
 
There was a significant amount of data and variables to decipher in this 
study. To help analyze the results, multiple types of research were used. 
Quantitative Research was used in this study. The examples of quantitative 
research used include: weight, ADG, AFI, DMI, ADMI, G:F ratio, and ELISA 
testing for IgA concentration. Experimental research was used because an 
experiment was conducted in order to give evidence to the experimental 
hypothesis. 
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It is hypothesized that receiving cattle offered scotch spearmint extract and 
a rumen undegradable protein-amino acid profile focused on immune response 
will have improved growth and feed efficiency.  
The collection of feed data was done through the GrowSafe System®. 
Every animal had an electronic tag in their ear to calculate the amount of feed 
they consumed and for what length of time. These recordings were taken twenty-
four hours a day. All six of the treatments were mixed with the same mixer and 
each week, samples of the ingredients, as well as the TMR, were taken and pooled 
at the end of the trial. The pooled samples were analyzed in our lab for: Dry 
Matter, Crude Protein, Acid Detergent Fiber, Neutral Detergent Fiber, Ether 
Extract, Ash, minerals, Total Digestible Nutrients, NEg, and NEm. 
The animals were weighed on day -1, 0, 21, 42, 63, and 64. On days 0, 21, 
and 42 a grab fecal sample was taken, as well as a blood sample taken from the 
jugular vein of three animals designated in each pen. These samples were 
extracted to test for the animal’s level of IgA. The IgA values in the blood and 
fecal samples were evaluated using the Epoch Plate Reader (BioTek, Winooski, 
VT) and a Bovine IgA ELISA kit (E11-131, Bethyl Laboratories, Inc., 
Montgomery, TX). All samples were kept frozen until analyzation, ran in 
triplicates, and the same standards were used in each test.  
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Chapter IV: Analysis 
Table 4.1 gives the nutrient composition of the dietary treatments. Tables 
4.2 and 4.3 depict that the treatments were designed to have a similar ingredient 
composition and deliver similar energy, crude protein, vitamins and mineral. 
Table 4.4 shows the effects of amino acid profile and essential oil product on 
receiving calf growth and feed efficiency. Table 4.5 illustrates intake and growth 
data comparisons between the AminoGain 6 and the AminoGain 6 Plus 
treatments. Table 4.6 represents the effects of treatments on serum IgA 
concentration of receiving cattle. 
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Table 4.1 Nutrient Composition of Dietary Treatments 
  
 
Supplement 
  1 2 3 4 5 6 
 AminoGain 6 AminoGain 6 Plus 
 Control Stay   
Strong 
EO 
Spearmint   
Ext 
Control Stay 
Strong 
EO 
Spearmint 
Ext 
% DM 90.80 91.04 91.02 90.59 90.94 90.11 
% CP 25.58 27.94 27.46 27.74 27.59 27.82 
% ADF 8.48 8.69 8.98 9.15 9.23 9.29 
% NDF  26.44 23.50 25.03 24.96 24.04 23.73 
% ASH 11.43 11.70 11.66 12.50 12.34 14.18 
% EE 4.42 4.53 4.48 4.85 4.62 4.43 
NEM (Mcal/cwt) 94.75 94.45 94.06 93.82 93.71 93.62 
NEG (Mcal/cwt) 64.52 64.27 63.93 63.73 63.64 63.56 
% TDN 84.79 84.58 84.29 84.10 84.02 83.96 
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Table 4.2 Dietary Ingredient Composition on a DMB for Mixing and 
Nutrient Composition   
                                                          
1 MDGS= Modified Distillers Grains plus solubles  
 
 
2 CSL= Corn Steep Liquor  
  1 2 3 4 5 6 
  AminoGain 6 AminoGain 6 Plus 
 
Control Stay   
Strong 
EO 
Spearmint   
Ext 
Control Stay 
Strong 
EO 
Spearmint Ext 
Ingredient % Dry Matter Basis 
Corn 38.2 38.2 38.2 40.4 40.4 40.4 
Grass hay   18.3 18.3 18.3 15.6 15.6 15.6 
MDGS1 7.3 7.3 7.3 7.0 7.0 7.0 
Ryelage   3.5 3.5 3.5 3.9 3.9 3.9 
CSL2 4.6 4.6 4.6 5.0 5.0 5.0 
Suppl 1 28.0 ---- ---- ---- ---- ---- 
Suppl 2 ---- 28.0 ---- ---- ---- ---- 
Suppl 3 ---- ---- 28.0 ---- ---- ---- 
Suppl 4 ---- ---- ---- 28.0 ---- ---- 
Suppl 5 ---- ---- ---- ---- 28.0 ---- 
Suppl 6 ---- ---- ---- ---- ---- 28.0 
Total 100.0 100.0 100.0 100.0 100.0 100.0 
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Table 4.3 Nutrient Profile on Dry Matter Basis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 
 AminoGain 6  AminoGain 6 Plus 
 Control Stay   
Strong 
EO 
Spearmint   
Ext 
Control Stay 
Strong 
EO 
Spearmint Ext 
DM, % 74.8 74.8 74.8 75.0 75.0 75.0 
NEg, Mcal/lb 0.53 0.53 0.53 0.53 0.53 0.53 
CP, % 15.9 15.9 15.9 16.0 16.0 16.0 
RDP, % 9.9 9.9 9.9 9.8 9.8 9.8 
RUP, % 6.0 6.0 6.0 6.2 6.2 6.2 
RUP, %CP 37.8 37.8 37.8 38.5 38.5 38.5 
Stay Strong EO --- +++ --- --- +++ --- 
Scotch Spearmint 
Ext 
--- --- +++ --- --- +++ 
48 
 
Table 4.4 Effects of Amino Acid Profile and Essential Oil Product on 
Receiving Calf Growth and Feed Efficiency 
 
 
  1 2 3 4 5 6   
 AminoGain 6 AminoGain 6 Plus   
 Control 
 
Stay 
Strong 
EO 
 
Spearmint 
Ext               
Control      Stay 
Strong 
EO                  
Spearmint 
Ext                   
SE P value 
Pens 2 2 2 2 2 2 - - 
Observations 20 20 20 20 20 20 - - 
BW, lb               
Initial 574.3 572.8 570.1 567.6 568.8 566.8 11.21 0.99 
d-21 661.0 660.0 658.0 670.0 665.0 648.0 13.39 0.77 
d-42 739.0 731.0 740.0 746.0 747.0 722.0 13.80 0.45 
d-63  810.1 807.0 819.3 823.5 825.8 796.8 14.90 0.33 
         
ADG, lbs/d               
d 0-21 4.12 4.17 4.18 4.85 4.56 3.87 0.32 0.26 
d 21-42 3.74 3.38 3.89 3.64 3.94 3.51 0.22 0.09 
d 42-63 3.38 3.61 3.79 3.69 3.74 3.57 0.22 0.46 
d 0-63 3.74ab 3.72ab 3.95ab 4.06a 4.08a 3.65b 0.13 0.02 
         
ADMI, lbs/d               
d 0-21 14.69 14.31 14.40 14.94 15.46 13.65 0.57 0.25 
d 21-42 19.95 18.88 18.97 19.99 20.32 18.14 0.50 0.07 
d 42-63 23.09 22.66 23.53 24.11 24.56 22.83 0.59 0.08 
d 0-63 19.24ab 18.61b 18.97ab 19.68a 20.11a 18.21b 0.47 0.06 
         
G:F               
d 0-21 0.2755 0.2908 0.2815 0.3228 0.2966 0.2751 0.019 0.321 
d 21-42 0.1906 0.1811 0.2093 0.1831 0.1945 0.1926 0.012 0.443 
d 42-63 0.1439 0.1620 0.1612 0.1535 0.1525 0.1559 0.009 0.535 
d 0-63 0.1944 0.2010 0.2086 0.2065 0.2034 0.1988 0.005 0.131 
ab Means within a row with different superscripts differ P ≤ 0.05 as a result of treatment. 
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Table 4.5 Comparison of AminoGain 6 and AminoGain 6 Plus 
Formulas 
 
 
 
Table 4.6 Effects of Amino Acid Profile and Essential Oil Products on 
Serum IgA Concentration of Receiving Cattle 
 
 AminoGain 6 
(Trmts 1-3) 
AminoGain 6 Plus 
(Trmts 4-6) 
SE P Value 
Small Pens  6 6 --- --- 
Calves  60 60 --- --- 
d 0-63 ADG lb/d 3.80 3.93 0.09 0.36 
d 0-63 ADMI lb/d  18.94 19.33 0.46 0.56 
d 0-63 G:F 0.201 0.203 0.005 0.82 
  Treatment   
  1 2 3 4 5 6   
 AminoGain 6 AminoGain 6 Plus   
 Control 
 
Stay 
Strong 
EO 
 
Spearmint 
Ext               
Control      Stay Strong 
EO      
Spearmint 
Ext        
SE P value 
Pens 2 2 2 2 2 2 - - 
Observations 20 20 20 20 20 20 - - 
IgA, ng/ml         
d-0 139.62 179.68 200.73 187.67 241.89 254.75 36.13 0.98 
d-21 248.95 377.32 287.25 266.37 291.06 403.37 89.45 0.53 
d-42  145.30 311.45 272.19 196.67 301.03 329.24 47.84 0.74 
d0-d21 ∆ 109.33 197.65 86.52 78.70 49.17 148.62 80.31 0.43 
d21-d42 ∆ -103.66 -65.87 -15.06 -69.70 9.96 -74.13 75.45 0.66 
d0-d42 ∆ 5.67 131.77 71.46 9.01 59.13 74.49 40.00 0.56 
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Chapter V: Results and Discussion 
In conclusion, results from the growth and feed intake data indicate that 
the effects of essential oils differ depending on the AminoGain formula in which 
they are paired with (Table 4.4). Intake may be inhibited by the inclusion of 
scotch spearmint extract or the addition of fishmeal to accomplish an increase in 
amino acids in the AminoGain 6 Plus formulas. Initial body weights were similar 
(P=0.99) among treatments. An interaction of AminoGain 6 formulation by 
essential oil source resulted (P<0.02) for cumulative ADG. Cumulative ADG did 
not differ (P≥0.05) with the addition of scotch spearmint or Stay Strong EO to the 
AminoGain 6 formula. However, the addition of scotch spearmint worsened 
(P<0.03) cumulative ADG when added to the AminoGain 6 Plus formula. This 
was likely the result of the cumulative feed intake which tended to worsen with 
the combination of scotch spearmint extract and AminoGain 6 Plus Formula 
(P≤0.06). Table 4.5 illustrates intake and growth data comparisons between the 
AminoGain 6 and the AminoGain 6 Plus treatments.  
Preliminary analysis indicated the Scotch Spearmint Extract was to be 
composed of 13% limonene and 70% carvone. Calculations for the initial amounts 
of supplement to be added to treatments were done using these figures. When the 
actual analysis came back, the extract contained .08% limonene and 91.73% 
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carvone. Because limonene was believed to have oxidized to carvone during 
storage, the quantity of active ingredients for the Scotch Spearmint Extract 
treatments differed from that in the plan of experiment. Although, carvone is 
reported to have similar activity as limonene, therefore an active component still 
existed for this trial. Using the preliminary analysis numbers, a target of 40 ppm 
limonene was chosen based on the trial done by Elwakeel et al. (2013), where 
they studied the effect of limonene on F. necrophorum (bacteria found in foot rot 
and liver abscesses) growth in vitro. These results suggested that 20-100 ppm 
limonene can be a promising tool to naturally reduce F. necrophorum and 
subsequently control liver abscesses. Therefore, it was determined the Scotch 
Spearmint extract treatments would contain 40 ppm, as that was somewhat 
intermediate. Although, Elwakeel’s et al. (2013) trial, only limonene was used. In 
this trial, scotch spearmint extract was fed which contained both limonene and 
carvone. There is a probability that what was fed was a much higher dose of 
active ingredients with the limonene and carvone combined. Because this dose 
was based on targeting a particular limonene concentration without regard to other 
active ingredients, the quantity of carvone in the diets may have been overdone. 
While adding essential oils to a diet may be able to increase weight gain, the 
scientific evidence on the effect in rumen microbial fermentation is limited. To be 
able to understand its influence, further studies are required, potentially in vitro or 
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in situ. Based on calculations using final lab analyses, each animal daily, on 
average, consumed 2.5 mg limonene, 2,821 mg carvone, and 5.5 mg eugenol. 
Concluding, a small amount of the oil has many positive effects, too much of the 
oil may have negative effects. This is definitely something to consider in the 
future when proceeding with trials containing essential oils.  
Stay Strong Essential Oils (SS EO; Ralco Inc., Marshall, MN) was 
targeted to deliver 1 g/100 lb body weight. This was dosed according to label 
instructions. It is an oregano based product which contains essential oils, 
including carvone. Based on calculations, on average each animal consumed 7.38 
g SS EO each day, consequently delivering 1.07 g/100 lb body weight. Therefore, 
our targeted 1g/100 lb bw was met.   
For this trial, a high health–risk group of cattle was targeted. With the 
exception of when Spearmint Extract was included, cattle fed the AminoGain 6 
Plus formula, in which the amino acid profile was designed for animals facing an 
immune challenge, gained 9% faster than cattle assigned to the AminoGain 6 
formula. Although this is only a numeric observation, evaluation of the 
AminoGain 6 Plus formula warrants further investigation because there are a 
number of unknowns related to Spearmint Extract and its chemical reactivity with 
other dietary components. The differences in the amino acids in the AminoGain 6 
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Plus formula was achieved by adding fishmeal. There is a possibility that the 
addition of fishmeal in combination with spearmint may have caused a 
palatability issue for the cattle. Since the inclusion of fishmeal numerically 
improved ADG when scotch spearmint was not included, the nutritional value of 
fishmeal or a fishmeal substitute, that still allows the opportunity to achieve the 
desired amount of amino acids, warrants further investigation.   
Due to its ability to increase feed efficiency and in order to avoid any 
skewing of results testing other products, monensin was not included in the diets 
in this trial. While monensin may not be a medically-important antibiotic, Tylan 
is. Tylan is used for the prevention of liver abscesses and was also not included in 
the test diets to avoid the possible skewing of results. 
The IgA results can be found in Table 4.6. Plasma IgA was measured 
because it’s found in both respiratory and intestinal mucosa with infection which 
may result with receiving calves. The difference in IgA concentration between d 0 
and d 42 tends to be higher. This observation warrants further investigation into 
the role of these compounds on the immune response. IgA concentrations in blood 
were not different (P > 0.05) as a result of treatment for any of the measured time 
points. Blood IgA concentrations were higher at d 21 and by d 42 had returned to 
similar to that of d 0. This time series progression is expected as 21 d after arrival 
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should be peak for animal experiencing symptoms of respiratory distress as a 
result of shipping and co-mingling, and by d 42 animals should be recovered. The 
samples were evaluated for IgA using the Epoch Plate Reader (BioTek, Winooski, 
VT) and a Bovine IgA ELISA kit (E11-131, Bethyl Laboratories, Inc., 
Montgomery, TX). They were ran in triplicates to increase the chances of a 
repeatable assay. The responsiveness of IgA assay to changing disease status 
make it an effective tool to assess gross disease state of receiving cattle. However, 
the dietary treatments in this trial were not effective in altering that disease state.  
For the fecal IgA analysis, two different protocols were attempted to 
develop an assay. The first protocol involved placing 1 gram of feces into 9 ml of 
purified water. The same Bovine IgA ELISA kit used in the serum IgA process 
was used for the fecal IgA. After achieving low results using the first protocol, it 
was decided to increase the amount of fecal used. In the next attempt, all other 
steps were identical besides 5 grams of the fecal sample was placed into 9 ml of 
water. With an increase in feces, higher concentrations in the results were 
achieved. However, the results were low, this may be due in part to the animals 
not suffering from disease challenge in the gastrointestinal tract. Therefore, fecal 
testing ceased and was not reported for these animals. While there was a large 
amount of variation in the results, the ability to evaluate IgA response to dietary 
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treatment provides a novel opportunity to further evaluate the efficacy of 
receiving calf treatments. 
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Appendix I: IACUC Approval Letter 
 
 
 
 
 
 
ANIMAL CARE AND USE PROTOCOL  
 
 
Project Title:  Effects of essential oils and amino acid profile on the growth and health 
of receiving cattle 
 
 
Protocol #:   B16102   
 
 
Principal Investigator: Dr. Aimee Wertz-Lutz         
 
 
Co-Investigator:   Jim Dunn 
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A.  ANIMAL DESCRIPTION 
 
 1. No. Animals used:  150 (120 on-test + 30 extra) 
                                                            
    2. Species:  Cattle 
                                                                  
   3. Strain/Stock:  Angus Crossbred 
                                                                               
    4. Age/Weight:  8 mo / 500 lbs.  
                                                                          
    5. Source:  Kansas Flinthills Region 
 
 6. Dates of Proposed Animal Use:  
  FROM:  9/30/2016      
  THROUGH:   2/1/2017         
                  
 7.  Have the animals been use for a previous study NO 
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B. DESCRIBE IN LAY TERMS:   
 1. The purpose and importance of the study: 
 
 To evaluate the health, growth, and feed intake of feedlot calves when fed 
essential oil supplements and diets of various amino acid formulations 
 
. JUSTIFY:  
 1.  The use of animals: 
 
 Growth performance, disease out-break, and feeding behavior cannot be 
simulated in a lab environment. 
 
 
 2.  The choice of species: 
 
 The specific purpose is to evaluate the response to essential oil and amino acid 
addition in beef cattle receiving programs.  
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C. PROJECT INFORMATION     
 
1. Identification and means for contacting personnel involved with this project: 
 Role/NAME  ADDRESSES  PHONE 
NUMBERS 
Principal Investigator 
(PI) 
OFFICE:  1000 N 30th St.  OFFICE:  217-231-2316 
Aimee Wertz-Lutz Quincy, IL 62305 CELL:  217-653-3351 
 E-MAIL:  aimee.wertz-lutz@adm.com HOME:   Click here to enter 
number.   
Co-Investigator OFFICE:  1000 N. 30th St. OFFICE:  217-231-2242 
Jim Dunn Quincy, IL 62305 CELL:  260-223-0098 
 E-MAIL:  jim.dunn@adm.com HOME:       Click here to 
enter number. 
Role:  Research Center 
Manager 
OFFICE:  1320 Hwy. 61 OFFICE:  217-936-2297 
Curt Nisbet Mendon, IL 62351 CELL:  217-257-3995 
 E-MAIL:  curt.nisbet@adm.com HOME:     Click here to 
enter number. 
Role:    Beef Research 
Coordinator 
OFFICE:   1320 Hwy. 61 OFFICE:   217-936-2250 
Dennis Miller Mendon, IL 62351 CELL:   217-430-4231 
 E-MAIL:   dennis.miller@adm.com HOME:    Click here to enter 
number. 
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C. PROJECT INFORMATION (cont.) 
2. Personnel Qualifications:  For the PI and each person with responsibility for any 
animal experimental manipulations, list prior experience and training in sufficient detail 
to allow the AACUC to determine that all personnel are qualified to perform animal 
related duties applicable to this project: 
 
Aimee Wertz-Lutz: PhD, 8 yrs. experience PI South Dakota State University; 20+ yrs. 
production animal research  
Jim Dunn: 20+yrs. experience with animal production and domestic animal research. 
Curt Nisbet: 20+ yrs. experience with animal production and animal research. 
Dennis Miller: 20+ yrs. experience with animal production and animal research. 
Mike Finlay: B.S. and 10+ yrs. Experience in swine and poultry production research. 
Julie Sampson: 20+ yrs. experience with dairy cattle and 10+ yrs. experience with animal 
research. 
John Swanson: 20+ experience in animal production and research. 
Alex Ippensen: 5+ yrs. experience Alliance Nutrition research Center. 
Laura Chockley: 3+ yrs. Vet technician; +10 yrs. Animal husbandry experience 
Terry Barry: Over 20 yrs. experience in animal production. 
Kelsey Machens: B.S. and 10+ yrs animal husbandry, 5+ yrs. Experience in animal 
production research. 
 
3.  Who will be the regularly attending veterinarian for these animals?  
 Name: Dr. Adam Gundel 
 Address: Western Illinois Veterinary Center; 3910 Wisman Lane, Quincy, IL 
62301 
 Phone #(s):  217-228-0414                                           
 
4. Are WILD ANIMALS to be used or studied?  NO 
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D. ANIMAL HUSBANDRY 
 
1. In which animal facility will animals be housed? (Give specific building(s) and 
room number(s) if known): 
  Mendon Beef Research Center 
 Twelve dry lot pens equipped with concrete fence line bunks and GrowSafe 
feeding bunks. 
  
2. Will animals be housed anywhere other than a designated animal housing facility 
for more than 12 hours (e.g., a laboratory)?   
  NO 
  
3.  Explain any nonstandard husbandry requirements (feeding, housing, 
environment): 
None 
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D. ANIMAL HUSBANDRY (cont.) 
 
4. Give a brief description or timeline of animal manipulations/procedures for study 
purposes: 
 This trial is intended to be a 63-d receiving calf trial in which the growth, intake, 
and health of newly arrived calves is evaluated. The trial will be designed as a 2x3 
factorial of amino acid formulation AminoGain 6 or AminoGain 6 Plus and essential oil 
product control which delivers no compound, Stay Strong EO at 1g/100 lb body weight, 
or scotch spearmint extract at 3.27 g/hd/d. The receiving product formulas will not have 
other antibiotics included. All treatments will be mixed into a complete feed. Water will 
be provided ad libitum.  
1) AminoGain 6 - Control 
2) AminoGain 6 – Stay Strong EO 
3) AminoGain 6 – Scotch Spearmint Extract 
4) AminoGain 6 Plus - Control 
5)          AminoGain 6 Plus - Stay Strong EO 
6)          AminoGain 6 Plus – Scotch Spearmint Extract 
 
Cattle will be implanted prior to initiation of the experiment with Synovex-S, vaccinated 
for respiratory disease, and treated for internal and external parasites. 
  
Cattle will be weighed on 2 consecutive days at trial initiation (d -1, and 0) and 
termination (d 63 and 64) and the weights averaged for initial and final weight. Single 
intermediate weights will be recorded at d 21 and 42. 
 
Rectal temperatures will be recorded at trial initiation. Cattle will be observed for 
respiratory and gastrointestinal disease outbreak. Rectal temperature may be recorded 
when other symptoms of respiratory disease are observed.  
 
Intake of the complete feed mix will be monitored daily using the GrowSafe individual 
cattle feeding system. 
 
Fecal and blood samples will be collected from 36 animals at d 0, 21, and 42. 
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E. DESCRIPTION OF NONSURGICAL PROCEDURES (answer all items 
below) 
  
NO   TISSUE COLLECTION from euthanatized animals 
YES SAMPLE COLLECTION from live animals 
  a.  Type of sample(s):   Fecal and blood                                                      
  b.  Volume of sample(s):   Fecal hand grab; blood 7-10 mL                                                    
  c.  Frequency of collection:  Days 0, 21, 42                                                 
  d.  Method of collection:    Fecal – grab sample; blood venipuncture                                                  
NO   INDUCED OR SPONTANEOUS NEOPLASIA in live animals. 
NO   Use of INFECTIOUS AGENT(S) in live animals           
 NO  Use of RECOMBINANT DNA in live animals.  
NO  Use of RADIOISOTOPE(S) in live animals 
NO Use of CARCINOGEN(S) in live animals 
NO  ANIMAL RESTRAINT lasting more than 30 minutes.     
NO   Will any nonsurgical procedure(s) INFLICT PAIN at a level or duration greater 
than a needle stick: 
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F. DESCRIPTION OF SURGICAL PROCEDURES 
1.  Will there be any surgical procedures?  NO    If "No", go to Section G. 
2. Name of procedure(s) to be performed:  Click here to enter text. 
3.  Justification of procedure(s):   Click here to enter text. 
4.   Person(s) responsible for performing surgery and postoperative care:                              
5.  What surgery facility will be used?    
6. Will any anesthetics, preanesthetics, or tranquilizers be used?    YES or NO   
 If "No", go to F.10. 
7. Anesthesia 
    a. Preanesthetic agent(s):Click here to enter agent. Dosage: Click here to enter 
dosage.Route:  Click here to enter route.        
    b. Anesthetic agent(s): Click here to enter agent. Dosage:  Click here to enter 
dosage. Route:   Click here to enter route. 
 c. Other agent(s): Click here to enter agent. Dosage: Click here to enter dosage. 
Route: Click here to enter route. 
 d. Monitoring and life support systems to be utilized to ensure adequate depth of 
analgesia or anesthesia and to prevent overdose: 
8. Complete description of post-anesthetic recovery monitoring and care:                                           
9.   YES or NO Animals will be euthanatized under anesthesia when surgery is 
completed. 
  YES or NO Animals will recover from anesthesia following surgery.  If 
"yes", answer a. and b. below: 
  a.  YES or NO Aseptic technique will be followed. 
b.  YES or NO Post-operative care will be provided and proper 
records will be maintained, including medications given. 
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F. DESCRIPTION OF SURGICAL PROCEDURES (cont.) 
 
10.  Describe post-operative care (include both short- and long-term care; monitoring, 
surgical wound care including suture removal, and list drugs and doses anticipated to be 
used) 
 
11.  Special needs of the animals following surgery: 
 
12.  Length of time animals will be kept alive following surgery: 
 
13.  Will animals be subjected to more than one major survival surgical (operative) 
procedure?  A major operative procedure is defined in Animal Welfare Act Regulations 
as any surgical intervention that penetrates and exposes a body cavity or any procedure 
which produces permanent impairment of physical or physiological functions.    
  YES or NO 
 
14. Have the animals to be used previously been subjected to a major survival 
surgical procedure on another protocol?              
YES or NO 
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G.  EUTHANASIA 
 
1.  Will animals be euthanized at the end of study?    NO 
 If "No", go to G.5. 
 
2.  List possible reasons for euthanasia: 
 
3.  Euthanasia agent/method:Click here to enter agent. Dose:Click here to enter 
dose.       
 
4.  If this method is not approved by the AVMA Panel on Euthanasia (2000)  , 
provide scientific justification for its use: 
 URL: http://www.avma.org/resources/euthanasia.pdf 
 (Note: After euthanasia is performed, death should be assured by bilateral 
pneumothorax, aortic transection, cervical dislocation, or some other certain physical 
means, as appropriate.) 
 
5.  How will the animals be disposed of at the end of the study? 
Cattle sold or shipped to an alternate location for finishing.  
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H.   INVESTIGATOR ASSURANCES 
 
1.  The information provided herein is accurate to the best of my knowledge.  
2. Procedures involving vertebrate animals will be performed only by trained or 
experienced personnel, or under the direct supervision of trained or experienced persons.  
3.  Accurate records of animal health and removal will be kept on file for AACUC 
inspections. 
4. Any change in the care and use of vertebrate animals involved in this protocol, 
which would affect the health and welfare of the animals, will be promptly forwarded to 
the AACUC for review. 
5. The number of animals proposed is the minimum necessary to conduct valid 
experimentation.  
6. I have conducted a literature search to ensure that I am not unnecessarily 
duplicating previous experiments. 
7. I have considered alternative methods to using animals.   
 
 
 
                                                                                           
_______________________________________________                                                                
___9/22/2016______ 
Signature of Principal Investigator or Co-Investigator               
  Date 
Please note: An electronic (Microsoft Word) copy of the protocol is required for 
processing.  Your email is considered an official, electronic signature, and will be kept on 
file for the duration of the protocol approval.  
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